Market Place
Sourcing Support
Ex dividend NOK 0.50 today
06 Nov 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Third quarter and YTD 2024 financial results
31 Oct 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Invitation to Q3 2024 conference call
24 Oct 2024 //
GLOBENEWSWIRE
Responsibility statement for first half year of 2024
21 Oct 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Mandatory notification of trade
26 Sep 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA Discloses Large Shareholding And Mandatory Trade
13 Sep 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Second quarter and first half 2024 financial results
23 Aug 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Mandatory notification of trade
23 Aug 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Invitation to Q2 2024 conference call
16 Aug 2024 //
GLOBENEWSWIRE
Vistin Pharma Ex dividend NOK 0.50 today
05 Jun 2024 //
GLOBENEWSWIRE
Disclosure of voting rights at AGM in Vistin Pharma ASA
23 May 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Minutes from the annual general meeting 2024
23 May 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024
30 Apr 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: First quarter 2024 financial results
24 Apr 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Annual Report 2023
24 Apr 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Invitation to Q1 2024 conference call
16 Apr 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Mandatory notification of trade
22 Mar 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)
04 Mar 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results
16 Feb 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Key information relating to the proposed cash dividend
16 Feb 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Invitation to Q4 2023 conference call
09 Feb 2024 //
GLOBENEWSWIRE
Ex dividend NOK 0.75 today
23 Jan 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Dividend of NOK 0.75 per share
11 Jan 2024 //
GLOBENEWSWIRE
Key information relating to the cash dividend to be paid by Vistin Pharma ASA
11 Jan 2024 //
GLOBENEWSWIRE
Vistin Pharma ASA: Mandatory notification of trade
18 Sep 2023 //
GLOBENEWSWIRE
Vistin Pharma ASA: Results of offer to buy back shares
04 Jul 2023 //
GLOBENEWSWIRE
Management in Vistin Pharma ASA purchases shares
04 Jul 2023 //
GLOBENEWSWIRE
Vistin Pharma ASA (OSE: VISTIN): Presentation from today`s Capital Markets Day
14 Jun 2023 //
GLOBENEWSWIRE
Vistin Pharma ASA: Mandatory notification of trade
30 May 2023 //
GLOBENEWSWIRE
Vistin Pharma ASA: Minutes from the Annual General Meeting 2023
22 May 2023 //
GLOBENEWSWIRE
Disclosure of voting rights at AGM in Vistin Pharma ASA
12 May 2023 //
GLOBENEWSWIRE
Vistin Pharma: Invitation to Capital Markets Day on 14th of June
11 May 2023 //
GLOBENEWSWIRE
Vistin Pharma ASA: Fourth quarter and preliminary 2022 financial results
17 Feb 2023 //
GLOBENEWSWIRE
Vistin Pharma ASA: Invitation to Q4 2022 conference call
10 Feb 2023 //
GLOBENEWSWIRE
Vistin Pharma enters into renewable energy supply agreement with Statkraft
09 Dec 2022 //
GLOBENEWSWIRE
Vistin Pharma ASA: Third quarter and YTD 2022 financial results
26 Oct 2022 //
GLOBENEWSWIRE
Vistin Pharma ASA: Invitation to Q3 2022 conference call
18 Oct 2022 //
GLOBENEWSWIRE
Vistin Pharma ASA: Second quarter and first half 2022 financial results
19 Aug 2022 //
GLOBENEWSWIRE
Vistin Pharma ASA: Minutes from the annual general meeting 2022
19 May 2022 //
GLOBENEWSWIRE
Vistin Pharma ASA: Notice of Annual General Meeting
28 Apr 2022 //
GLOBENEWSWIRE
Vistin Pharma ASA: First quarter 2022 financial results
27 Apr 2022 //
GLOBENEWSWIRE
Vistin Pharma ASA: Annual Report for 2021
27 Apr 2022 //
GLOBENEWSWIRE
Vistin Pharma ASA: Second quarter and first half 2021 financial results
19 Aug 2021 //
GLOBENEWSWIRE
TPI buys CMO biz to move into opioid drug production
21 Jul 2017 //
FIERCE PHARMA
